Life ScienceCompany
Mayne Pharma Group has acquired 4 companies. It has also divested 2 assets.
Mayne Pharma Group’s largest acquisition to date was in 2012, when it acquired Metrics for $120M. It’s largest disclosed sale occurred in 2022, when it sold Metrics Contract Services to Catalent for $475M. Mayne Pharma Group has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to Mayne Pharma Group’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity6
- M&A Buy Activity4
- M&A Sell Activity2
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 3